Ignite Creation Date:
2024-05-05 @ 11:37 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00098423
Status:
COMPLETED
Last Update Posted:
2013-09-30
First Post:
2004-12-07
Brief Title:
Tanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Chronic Myelogenous Leukemia Chronic Myelomonocytic Leukemia or Myelodysplastic Syndromes
Sponsor:
Organization:
National Cancer Institute NCI